at @mskcancercenter.bsky.social commencement, beyond proud our pd Seungjae Lee awarded the Tri-I Breakout Prize, endowed by Breakthrough Prize to Sawyers/Bargmann/Cantley. And, Phil Sharp given honorary degree, his work foundational to Seungjae's studies on splicing and small RNA therapeutics. 🧬

Today, 15 new PhD scientists will officially receive their degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) as part of the 47th annual academic convocation and commencement ceremony held at MSK. Learn more about these graduates: https://bit.ly/4dnuvuD

(1/2) An MSK team led by researchers Dr. Anthony Daniyan and @oawlab.bsky.social has developed a new preclinical CAR T cell therapy approach for #AML that targets a protein found almost exclusively on #leukemia cells and not on healthy blood cells.

New research from MSK reveals how #pancreatic cancer cells organize themselves to fuel tumor growth; finds an antibody-drug conjugate shows efficacy in rare pediatric #sarcoma; develops an #AI tool could accelerate identification of disease-causing genetic variants; and more: https://bit.ly/4wkxj47

Excited to announce a new paper out now in Cancer Discovery @aacrjournals.bsky.social on a unique CAR T cell platform that eliminates AML and B-ALL without harming vital endogenous immune cells or other normal human tissues: pubmed.ncbi.nlm.nih.gov/42059863/

Exercise physiology researcher Dr. Jessica Scott sat down with @npr.org for a conversation about the best type of exercise to boost mobility and prevent injury. Learn more about the benefits of explosive power training below. @mskcancercenter.bsky.social

Detection of cytokine release syndrome (#CRS) using #wearables and cytokine profiling following #CAR-T therapy for #myeloma @insight.jci.org @mskcancercenter.bsky.social jci.org/articles/vie...

🎉 Congratulations to MSK computational biologist @caleblareau.bsky.social on being awarded a 2026 Pershing Square Sohn Cancer Prize. His work will focus on engineered protein “sponges” to absorb and neutralize chemotherapy drugs and reduce harmful side effects.

Now online in Cancer Discovery @aacrjournals.bsky.social: Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute Leukemias - by Takeshi Fujino, Jennifer Lewis, @oawlab.bsky.social, Anthony Daniyan, et al. doi.org/10.1158/2159... @mskcancercenter.bsky.social

Congratulations to MSK's most recent awards & appointments, including Dr. Christopher Lima for being named a 2025 Fellow of the @aaas.org, @ssraj017.bsky.social and Satoshi Kaito for being awarded a @dkms-uk.bsky.social John Hansen Research Grant, and more: www.mskcc.org/news-release...

As neurology enters the era of high-cost therapies, financial toxicity is becoming a key determinant of access, adherence, and equity. Proud to work with superstar resident Dr. Gotlieb on this viewpoint in @greenjournal.bsky.social neurology.org/doi/full/10.... @mskcancercenter.bsky.social

Congratulations to MSK developmental biologist Dr. Anna-Katerina Hadjantonakis and MSK physician-scientist Dr. Robert Farese who were elected to the 2026 class of the American Academy of Arts and Sciences. Learn more: https://bit.ly/427X21Z

New research from MSK, published in @nature.com, shows how lung cells with cancer-causing mutations recruit surrounding healthy tissue to support tumor formation. Changes to the tumor microenvironment begin early and help drive growth and progression. Learn more: https://bit.ly/3QyDfGw

During #AACR26, researchers from MSK presented on innovative therapeutic advances, including clinical trials showing promise for people with early-stage HER2-driven #rectalcancer and KRAS-driven #pancreaticcancer, and more. https://bit.ly/4tqK8bc

MSK experts presented findings from their latest foundational and translational oncology research at #AACR26. This roundup includes studies on #pancreaticcancer, #rectalcancer, and #lungcancer: https://bit.ly/4tryIEa @theaacr.bsky.social#AACR26

Join MSK senior research scientist Shiv Verma for his session on “STARD13-LATS2 Axis as a potential genetic modifier of BRCA2 in #breastcancer” TODAY at #AACR26. @theaacr.bsky.social#breastcancer#AACR26 ⏱️: Tuesday, April 21 at 4:05pm PDT Learn more: https://bit.ly/4e2pFVC

MSK gastrointestinal medical oncologist Dr. Eileen O'Reilly led a very promising phase 1/2 clinical trial of the targeted RAS therapy #daraxonrasib for people facing #pancreaticcancer. Learn more about this research presented at #AACR26: https://bit.ly/4coBGmW @theaacr.bsky.social#daraxonrasib#pancreaticcancer

Join MSK research scholar Silvia Palladino for her session on “Combining RAS inhibitors with the clinical RNR inhibitor BBI-825 to prevent the emergence of extrachromosomal DNA (ecDNA)-driven resistance to RAS-targeted therapies in #colorectalcancer” TODAY at #AACR26. @theaacr.bsky.social#colorectalcancer#AACR26

Join MSK senior research scientist Peng Li for her session on “Evasion of hepatic ILC1 immunosurveillance drives #breastcancer liver metastasis” TODAY at #AACR26. @theaacr.bsky.social#breastcancer#AACR26 ⏱️: Tuesday, April 21 at 2:35pm PDT Learn more: https://bit.ly/42moitC

Join MSK leukemia specialist Dr. @oawlab.bsky.social for his session about "RNA processing regulation of anti-tumor immune responses" TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️: Tuesday, April 21 at 1:25pm PDT Learn more: https://bit.ly/4tq8pyphttps://bit.ly/4tq8pyp

#AACR26 session alert: Dr. Joseph Minhow Chan shares research on #lungcancer. ⬇️

Join gastrointestinal medical oncologist Dr. Luis Diaz for his session about “Chemical engineering of mismatch repair deficiency to induce tumor immunogenicity” TODAY at #AACR26. @theaacr.bsky.social#AACR26e ⏱️: Tuesday, April 21 at 1:25pm PDT Learn more: https://bit.ly/4cueKBm

Join MSK breast medical oncologist Dr. Sarat Chandarlapaty for a session about “Resistance to anti-HER2 ADCs” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️: Tuesday, April 21 at 1:25pm PDT Learn more here: https://bit.ly/4934sY2 #AACR26

Join principal investigator @caleblareau.bsky.social for a session about “Population scale sequencing resolves the determinants and consequences of persistence #EpsteinBarrVirus infection” TODAY at #AACR26. ⏱️: Tuesday, April 21 at 1pm PDT Learn more here: https://bit.ly/4mKNiUS

NEW Review article by Ming Li and colleagues @mskcancercenter.bsky.social @weillcornell.bsky.social discusses how monocytes and macrophages respond to cancer cells as 'infectious self', having both pathogen-like and self-like features

Poster sessions start in one hour. Don't miss Dr. Brian Chernak's research. ⬇️ #AACR26

Join MSK leukemia specialist Dr. Omar Abdel-Wahab for a session about “From molecules to medicine – driving breakthroughs in blood cancer treatment” TODAY at #AACR26. ⏱️: Monday, April 20 at 6:45pm PDT Learn more here: https://bit.ly/48Z0tf3

MSK radiochemist @lewislabmskcc.bsky.social shared an insightful presentation about questions and new opportunities in #theranostics at #AACR26. @theaacr.bsky.social

Join Dr. Vinod Balachandran, an MSK physician-scientist and Director of The Olayan Center for Cancer Vaccines, for a Major Symposium sharing new research about “Personalized neoantigen vaccines for #pancreaticcancer” TODAY at #AACR26. @theaacr.bsky.social#pancreaticcancer#AACR26 Learn more: https://bit.ly/4vMl7ZY

Day 3️⃣ of #AACR26 is kicking off! @theaacr.bsky.social

Join MSK radiochemist Dr. @lewislabmskcc.bsky.social for a session about “New questions and new opportunities in theranostics” TODAY at #AACR26. @theaacr.bsky.social#AACR26 Monday, April 20 at 10:36am PDT Learn more here: https://bit.ly/4dTR0cr

Join MSK's Dr. Kevin Boehm for a session about “Multimodal modeling of detailed cancer subtypes and molecular features from >60,000 patients with co-registered H&E images and clinical tumor sequencing” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️: Sunday, April 19 3:05pm PDT https://bit.ly/4vGnhdn

Next up at #AACR: Join MSK gynecologic medical oncologist Dr. Rachel Grisham for a session titled “Approaches to drug development for rare malignancies” TODAY. @theaacr.bsky.social#AACR ⏱️: Sunday, April 19 at 1:30pm PDT Learn more here: https://bit.ly/41F7aPF

Join MSK genitourinary medical oncologist Dr. David Solit for a session about “Advancing target discovery for rare cancers through institutional-scale molecular profiling and social media outreach” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️: Sunday, April 19 at 1:55pm PDT https://bit.ly/4cznSov

Join MSK computation biologist Dana Pe’er for a session about “When form meets function: Decoding tissue architecture” TODAY at #AACR26. ⏱️: Sunday, April 19 at 1:30pm PDT Learn more here: https://bit.ly/4tpoqVg

Don't miss the chance to meet with MSK's Dr. Luis Diaz at #AACR26. ⬇️

Join MSK leukemia specialist and physician-scientist Dr. Ross Levine for a session titled “Targeting epigenetic dependencies in myeloid malignancies” TODAY at #AACR26. ⏱️ : Sunday, April 19 at 1:30pm PDT Learn more here: https://bit.ly/4mG5f79

Join MSK gastrointestinal medical oncologist Dr. Yelena Janjigian for a session about “Resectable gastroesophageal cancer: Time to rewrite the standard” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️: Sunday, April 19 at 1:25pm PT Learn more here: https://bit.ly/4ew74kO

An experimental vaccine using #mRNA to prevent #pancreaticcancer from returning after surgery continues to show promise in a 16-person patient group. Results show that nearly 90% of people whose immune systems responded to the vaccine were still alive 6 years later. https://bit.ly/3Oebu5n

This morning, @rosslevinemd.bsky.social, Chief Scientific Officer at MSK, and Dr. Kenneth Offit, Chief of the Clinical Genetics Service at MSK, were recognized as new members of the 2026 class of the AACR Academy of Fellows during the Opening Ceremony at #AACR26. @theaacr.bsky.social#AACR26👏

Join MSK leukemia specialist Dr. Charles Sawyers for a session titled “How cancer cells escape targeted therapy by changing identity” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️ : Sunday, April 19 at 9:40am PDT Learn more here: https://bit.ly/4vENaKs

A small clinical trial (8-person) at MSK, led by Drs. Michael Foote and Andrea Cercek, is showing promise for people with early-stage #rectalcancer whose tumors are driven by excessive amounts of a protein called #HER2. Learn more about this research: https://bit.ly/4sKCZ4G #AACR26

Join MSK cancer biologist Dr. @marasherman.bsky.social for a session about “Identifying stromal barriers to pancreatic tumorigenesis” TODAY at #AACR26. @theaacr.bsky.social#AACR26 ⏱️ : Saturday, April 18 at 1pm PDT Learn more here: https://bit.ly/3OeaL46

Join Dr. Michael Foote for a session on “Genomic HER2 amplification predicts for complete clinical response in a phase II study of induction tucatinib and trastuzumab combined with chemotherapy in locally advanced #rectal #adenocarcinoma” at #AACR26. @theaacr.bsky.social#rectal#adenocarcinoma#AACR26 https://bit.ly/42etwHP

Don't miss this important #AACR26 sessions with Dr. Karuna Ganesh this morning! ⬇️

Today kicks off #AACR26! Follow along on our social channels from April 17-22 for live updates and to hear from our MSK experts in attendance.

Join MSK molecular geneticist Dr. Michael Berger for a session titled “From sequencing to treatment: The role of AI in precision oncology” TODAY at @theaacr.bsky.social. ⏱️ : Friday, April 17 at 4:01pm PT Learn more: https://bit.ly/3OLRLdh #AACR26

New research from MSK, led by Dr. Scott Lowe, Dr. Dana Pe'er, & colleagues, shows how pancreatic cells can shift from a benign state to cancer — revealing a key “switch” in this process. The study, published in @cellpress.bsky.social, identifies a critical window for early detection and prevention.

Physicians and scientists from MSK will join oncology experts and members of the global #cancerresearch community to present the latest advances in cancer discovery at the @theaacr.bsky.social Annual Meeting 2026, taking place April 17–22. Learn more: https://bit.ly/4mwEK3C #AACR26

Congratulations to Dr. Karuna Ganesh and Dr. Andrew Intlekofer on being elected members of the American Society for Clinical Investigation, one of the nation's most prestigious honor societies for physician-scientists! @karunamdphd.bsky.social @the-asci.org @mskcancercenter.bsky.social